Tectonic Therapeutic (TECX) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net selling: insiders sold $14K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$14K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about TECX filings

Are insiders buying or selling Tectonic Therapeutic, Inc. (TECX) stock?

Net selling: insiders sold $14K and bought $0 of TECX stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. $14K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was McNamara, Peter (Chief Scientific Officer), who sold $14K. The latest filing was on Oct 2, 2026.

Which members of Congress have traded TECX recently?

None. No member of Congress disclosed a TECX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this TECX smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Filings could not be loaded.

16 funds hold a position and insiders have been net selling.

Questions about TECX filings

Are insiders buying or selling Tectonic Therapeutic, Inc. (TECX) stock?

Which members of Congress have traded TECX recently?

None. No member of Congress disclosed a TECX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this TECX smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Sold$21K

Sells (3)

MP
Mcnamara Peter
Chief Scientific Officer · Oct 2
$12K
sold
MP
Mcnamara Peter
Chief Scientific Officer · Aug 26
$2K
sold
MP
Mcnamara Peter
Chief Scientific Officer · Aug 14
$2K
sold

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 5, 2026

Earnings came in 10.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 5, 2026

Period ending

Sep 30, 2026

Earnings per share

-$1.08+10.53% beat

-$1.21 expected

Revenue

$0.00

SEC filing · No operating revenue

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 5, 2026	-$1.08est. -$1.21	+10.53%beat	$0.00SEC filing	No year-ago quarter
Jun 30, 2026Reported Aug 6, 2026	-$1.18est. -$1.41	+16.31%beat	$0.00SEC filing	No year-ago quarter
Mar 31, 2026Reported May 7, 2026	-$1.34est. -$1.17	-14.53%miss	$0.00Alpha Vantage	No year-ago quarter
Dec 31, 2025Reported Feb 26, 2026	-$1.03est. -$1.11	+7.21%beat	$0.00Alpha Vantage	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$1.02est. -$1.05	+2.86%beat	$0.00Alpha Vantage	No year-ago quarter
Jun 30, 2025Reported Aug 7, 2025	-$1.07est. -$0.98	-9.18%miss	$0.00Alpha Vantage	No year-ago quarter
Mar 31, 2025Reported May 8, 2025	-$0.93est. -$1.09	+14.68%beat	$0.00Alpha Vantage	No year-ago quarter
Dec 31, 2024Reported Mar 20, 2025	-$0.84est. -$1.39	+39.68%beat	$0.00Alpha Vantage	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $21.75
High: $21.75
Low: $20.20
Prev close: $21.96
52-wk high: $39.53
52-wk low: $16.77
Mkt cap: $411.3M
ROE: -35.5%
Beta: 0.50
P/B: 1.9x
Profit margin: +0.0%
Op margin: +0.0%

Sep 2025 to Jun 2026

What it sold, what it cost, what was left.

RevenueProfit

Sep 2025Dec 2025Mar 2026Jun 2026

Income statement, 4 periods, all values in US dollars
USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
What came in
RevenueTotal revenue	$0	$0	$0	$0
What it spent
Research and development	$16.9M	$16.3M	$20.9M	$18.0M
Sales and adminSelling, general and administrative	$5.0M	$5.2M	$6.4M	$6.2M
Total operating expenses	$21.9M	$21.5M	$27.3M	$24.2M
What was left
Operating profitOperating income	-$21.9M	-$21.5M	-$27.3M	-$24.2M
Interest on debtInterest expense	$14.0K	$12.0K	$8.0K	$6.0K
Profit before tax	-$19.0M	-$19.0M	-$25.2M	-$22.2M
TaxIncome tax expense	—	$254.0K	—	$77.0K
Net profitNet income	-$19.0M	-$19.2M	-$25.2M	-$22.3M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$18.7M	-$18.3M	-$24.9M	-$21.9M

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

35 / 100

RSI 14

56balanced

20D volatility

58%annualized

52-week range

$21.04

$16.77$39.53

20D support

$18.54recent floor

20D resistance

$22.80recent ceiling

Returns

5D +8.3%20D -1.2%60D -43.2%

Price vs moving averages

SMA20 +1.9%SMA50 -10.4%SMA200 -25.2%

Volume pace

0.71xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 5, 2026

-$1.08est. -$1.21

+10.53%

$0.00SEC filing

No year-ago quarter

Jun 30, 2026Aug 6, 2026

-$1.18est. -$1.41

+16.31%

$0.00SEC filing

No year-ago quarter

Mar 31, 2026May 7, 2026

-$1.34est. -$1.17

-14.53%

$0.00Alpha Vantage

No year-ago quarter

Dec 31, 2025Feb 26, 2026

-$1.03est. -$1.11

+7.21%

$0.00Alpha Vantage

No year-ago quarter

Sep 30, 2025Nov 6, 2025

-$1.02est. -$1.05

+2.86%

$0.00Alpha Vantage

No year-ago quarter

Jun 30, 2025Aug 7, 2025

-$1.07est. -$0.98

-9.18%

$0.00Alpha Vantage

No year-ago quarter

Mar 31, 2025May 8, 2025

-$0.93est. -$1.09

+14.68%

$0.00Alpha Vantage

No year-ago quarter

Dec 31, 2024Mar 20, 2025

-$0.84est. -$1.39

+39.68%

$0.00Alpha Vantage

No year-ago quarter

Income statement, 4 periods, all values in US dollars
USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
What came in
RevenueTotal revenue	$0	$0	$0	$0
What it spent
Research and development	$16.9M	$16.3M	$20.9M	$18.0M
Sales and adminSelling, general and administrative	$5.0M	$5.2M	$6.4M	$6.2M
Total operating expenses	$21.9M	$21.5M	$27.3M	$24.2M
What was left
Operating profitOperating income	-$21.9M	-$21.5M	-$27.3M	-$24.2M
Interest on debtInterest expense	$14.0K	$12.0K	$8.0K	$6.0K
Profit before tax	-$19.0M	-$19.0M	-$25.2M	-$22.2M
TaxIncome tax expense	—	$254.0K	—	$77.0K
Net profitNet income	-$19.0M	-$19.2M	-$25.2M	-$22.3M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$18.7M	-$18.3M	-$24.9M	-$21.9M

USD

Sep 2025

Dec 2025

Mar 2026

Jun 2026

What came in

RevenueTotal revenue

What it spent

Research and development

$16.9M

$16.3M

$20.9M

$18.0M

Sales and adminSelling, general and administrative

$5.0M

$5.2M

$6.4M

$6.2M

Total operating expenses

$21.9M

$21.5M

$27.3M

$24.2M

What was left

Operating profitOperating income

-$21.9M

-$21.5M

-$27.3M

-$24.2M

Interest on debtInterest expense

$14.0K

$12.0K

$8.0K

$6.0K

Profit before tax

-$19.0M

-$25.2M

-$22.2M

TaxIncome tax expense

—

$254.0K

—

$77.0K

Net profitNet income

-$19.0M

-$19.2M

-$25.2M

-$22.3M

EBITDAEarnings before interest, tax, depreciation, amortisation

-$18.7M

-$18.3M

-$24.9M

-$21.9M

Tectonic Therapeutic, Inc.

Smart money at a glance

What do analysts expect?

Questions about TECX filings

Questions about TECX filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 10.5% above what analysts expected.

What the street expects next

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Tectonic Therapeutic, Inc.

Smart money at a glance

What do analysts expect?

Questions about TECX filings

Questions about TECX filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 10.5% above what analysts expected.

What the street expects next

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Tectonic Therapeutic, Inc.

Overview

Questions about TECX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Tectonic Therapeutic, Inc.

Overview

Questions about TECX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.